Presentation TCT 2012 Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel Presenter: Jean-Pierre P. Dery, Abdelouahed Khalil, Ugo D?ry, M?lanie Roy, Pierluigi Tricoci, Richard Becker, Stéphane Rinfret, Éric Larose, G?rald Barbeau, Robert DeLarochelli?re, Josep Rod?s-Cabau, Olivier F. Bertrand January 03, 2012
News Daily News Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response January 03, 2012
Presentation TCT 2012 Inhibition of Platelet Aggregation by Prostaglandin E1 (PGE1) May Be Attenuated in Diabetic Patients During Therapy with Clopidogrel Presenter: Rolf P. Kreutz, Perry Nystrom, Yvonne Kreutz, Jiao Miao, Richard Kovacs, David Flockhart, Zeruesenay Desta, Yan Jin January 03, 2012
Presentation TCT 2012 Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention Presenter: Andr?s Kom?csi, Orsolya Rideg, Gy?ngyv?r K?lt?, Andr?s Vorobcsuk, Daniel Aradi January 03, 2012
Presentation TCT 2012 Genetic Determinants of Clopidogrel Responsiveness in Koreans Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuk Kang, Hyo Suk Ahn, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 03, 2012
Presentation TCT 2012 CYP3A4 Genetic Status May Be Associated with Increased Vulnerability to the Adverse Effect of Calcium Channel Blockers on Clopidogrel Response Variability Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuk Kang, Hyo Suk Ahn, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim January 03, 2012
Presentation CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events Presenter: Michael V. Holmes January 03, 2012
Presentation TCT 2012 Clopidogrel Hyporesponsiveness, Interacting with Diabetes Mellitus, Predicts 2-Year Cardiovascular Outcome Among Taiwanese Population Underging Percutaneous Coronary Intervention Presenter: Ping-Yen Liu, Ling-Jay Hsu, Po-Tseng Lee, Cheng-Hann Lee, Ju-Yi Chen, Yi-Heng Li, Liang-Miin Tsai, Jyh-Hong Chen January 03, 2012
News Conference News SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel November 21, 2011
News Conference News Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity November 17, 2011
News Conference News Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes November 16, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011
News Daily News Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients November 02, 2011
News Daily News Genetic Predictors of Early Stent Thrombosis Identified L.A. McKeown October 25, 2011
News Daily News High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated Jason Kahn October 24, 2011
News Daily News STEMI Patients Benefit From Clopidogrel Given Prior to PCI Center Caitlin E. Cox September 28, 2011
News Daily News Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients Jason Kahn September 26, 2011
News Daily News Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI Yael L. Maxwell September 26, 2011